These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21047537)

  • 1. Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapy.
    Abdalla MO; Karna P; Sajja HK; Mao H; Yates C; Turner T; Aneja R
    J Control Release; 2011 Feb; 149(3):314-22. PubMed ID: 21047537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced noscapine delivery using estrogen-receptor-targeted nanoparticles for breast cancer therapy.
    Madan J; Gundala SR; Kasetti Y; Bharatam PV; Aneja R; Katyal A; Jain UK
    Anticancer Drugs; 2014 Jul; 25(6):704-16. PubMed ID: 24642711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of nanoscale based drug delivery systems in delivery and targeting tubulin binding agent, noscapine in cancer cells.
    Chandra R; Madan J; Singh P; Chandra A; Kumar P; Tomar V; Dass SK
    Curr Drug Metab; 2012 Dec; 13(10):1476-83. PubMed ID: 22571485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer.
    Ahmed MSU; Salam AB; Yates C; Willian K; Jaynes J; Turner T; Abdalla MO
    Int J Nanomedicine; 2017; 12():6973-6984. PubMed ID: 29033565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.
    Yang L; Sajja HK; Cao Z; Qian W; Bender L; Marcus AI; Lipowska M; Wood WC; Wang YA
    Theranostics; 2013; 4(1):106-18. PubMed ID: 24396518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles.
    Yang L; Mao H; Cao Z; Wang YA; Peng X; Wang X; Sajja HK; Wang L; Duan H; Ni C; Staley CA; Wood WC; Gao X; Nie S
    Gastroenterology; 2009 May; 136(5):1514-25.e2. PubMed ID: 19208341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhalable nanostructured lipid particles of 9-bromo-noscapine, a tubulin-binding cytotoxic agent: in vitro and in vivo studies.
    Jyoti K; Kaur K; Pandey RS; Jain UK; Chandra R; Madan J
    J Colloid Interface Sci; 2015 May; 445():219-230. PubMed ID: 25622047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Receptor Targeted Magnetic Iron Oxide Nanoparticles for Efficient Drug Delivery and Tumor Imaging.
    Yang L; Cao Z; Sajja HK; Mao H; Wang L; Geng H; Xu H; Jiang T; Wood WC; Nie S; Wang YA
    J Biomed Nanotechnol; 2008 Dec; 4(4):439-449. PubMed ID: 25152701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DOT corrected fluorescence molecular tomography using targeted contrast agents for small animal tumor imaging.
    Tan Y; Cao Z; Sajja HK; Lipowska M; Wang YA; Yang L; Jiang H
    J Xray Sci Technol; 2013; 21(1):43-52. PubMed ID: 23507851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis.
    Sebak S; Mirzaei M; Malhotra M; Kulamarva A; Prakash S
    Int J Nanomedicine; 2010 Sep; 5():525-32. PubMed ID: 20957217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer.
    Lee GY; Qian WP; Wang L; Wang YA; Staley CA; Satpathy M; Nie S; Mao H; Yang L
    ACS Nano; 2013 Mar; 7(3):2078-89. PubMed ID: 23402593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor-targeted nanoparticles for in vivo imaging of breast cancer.
    Yang L; Peng XH; Wang YA; Wang X; Cao Z; Ni C; Karna P; Zhang X; Wood WC; Gao X; Nie S; Mao H
    Clin Cancer Res; 2009 Jul; 15(14):4722-32. PubMed ID: 19584158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery.
    Gao N; Bozeman EN; Qian W; Wang L; Chen H; Lipowska M; Staley CA; Wang YA; Mao H; Yang L
    Theranostics; 2017; 7(6):1689-1704. PubMed ID: 28529645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-circulating poly(ethylene glycol)-grafted gelatin nanoparticles customized for intracellular delivery of noscapine: preparation, in-vitro characterization, structure elucidation, pharmacokinetics, and cytotoxicity analyses.
    Madan J; Dhiman N; Sardana S; Aneja R; Chandra R; Katyal A
    Anticancer Drugs; 2011 Jul; 22(6):543-55. PubMed ID: 21471809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular Image of Superparamagnetic Iron Oxide Nanopariticle Labeled with hATF in Colon Tumor Models].
    Zhang S; Wang L; Chen L; Xu H; Wu Q; Bi F; Gao F; Xu F
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Oct; 32(5):1067-74. PubMed ID: 26964313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of peptide conjugated magnetic nanoparticles to urokinase plasminogen activator receptor (uPAR) expressing cells.
    Hansen L; Larsen EK; Nielsen EH; Iversen F; Liu Z; Thomsen K; Pedersen M; Skrydstrup T; Nielsen NC; Ploug M; Kjems J
    Nanoscale; 2013 Sep; 5(17):8192-201. PubMed ID: 23835641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
    Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
    J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and optimization of noscapine nanosuspensions and study of its cytotoxic effect.
    Azarian M; Amani A; Faramarzi MA; Divsalar A; Eidi A
    J Biomol Struct Dyn; 2019 Jan; 37(1):147-155. PubMed ID: 29283030
    [No Abstract]   [Full Text] [Related]  

  • 19. Activation of urokinase plasminogen activator and its receptor axis is essential for macrophage infiltration in a prostate cancer mouse model.
    Zhang J; Sud S; Mizutani K; Gyetko MR; Pienta KJ
    Neoplasia; 2011 Jan; 13(1):23-30. PubMed ID: 21245937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer.
    Miller-Kleinhenz J; Guo X; Qian W; Zhou H; Bozeman EN; Zhu L; Ji X; Wang YA; Styblo T; O'Regan R; Mao H; Yang L
    Biomaterials; 2018 Jan; 152():47-62. PubMed ID: 29107218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.